A carregar...

Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder:A Systematic Review of Clinical Trials

OBJECTIVE: Desvenlafaxine is the third serotonin-norepinephrine reuptake inhibitor (SNRI) approved by the US Food and Drug Administration for major depressive disorder (MDD). This article summarizes data on the clinical pharmacology, efficacy, safety, and tolerability of desvenlafaxine (administered...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liebowitz, Michael R., Tourian, Karen A.
Formato: Artigo
Idioma:Inglês
Publicado em: Physicians Postgraduate Press, Inc. 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2947544/
https://ncbi.nlm.nih.gov/pubmed/20944767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.09r00845blu
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!